![Alain Maïore](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alain Maïore
Fondateur chez Mnemo Therapeutics SAS
Postes actifs de Alain Maïore
Sociétés | Poste | Début | Fin |
---|---|---|---|
Mnemo Therapeutics SAS
![]() Mnemo Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Mnemo Therapeutics SAS is a French biotechnology company that develops cell therapies to create accessible cures for cancer patients. The company is based in Paris, FR, and has subsidiaries in the United States. The company applies a novel approach to cell therapy using its enfinit platform, a groundbreaking drug discovery engine. Mnemo is committed to addressing the challenges in the field of immuno-oncology, such as a lack of cancer-specific targets, long-term persistence, and sensitivity. The company aims to engineer the future of immunotherapies to transform the lives of people with cancer by discovering novel cancer-specific targets and boosting immune activity to treat solid tumors. The company was founded in 2019 by Alain Maïore and Michel Sadelain. Robert LaCaze has been the CEO of the company since 2022. | Directeur/Membre du Conseil | 01/01/2019 | - |
Directeur des opérations | 01/05/2022 | - | |
Fondateur | 01/01/2019 | - | |
Directeur Général | 01/01/2019 | 01/05/2022 |
Historique de carrière de Alain Maïore
Anciens postes connus de Alain Maïore
Sociétés | Poste | Début | Fin |
---|---|---|---|
Kurma Partners SA
![]() Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Directeur/Membre du Conseil | 25/11/2009 | 13/08/2012 |
Fondateur | 13/08/2012 | 30/09/2012 | |
Ventech SA
![]() Ventech SA Investment ManagersFinance Ventech SA is part of the venture capital arm and a wholly-owned subsidiary of Natixis Private Equity (NPE), which in turn is a subsidiary of Paris-based Natixis SA (XP: KN). Ventech was established in 1998 and is located in Paris. The firm specializes in technology venture capital investing. Ventech manages venture capital funds for a clientele of European institutional investors, with NPE as their sponsor. The firm relies on international strategic alliances with seeding funds and venture capital firms in Germany, Switzerland, Israel, Japan and the US. | Private Equity Investor | 01/01/2001 | 01/09/2009 |
Intrexon ActoBiotics NV
![]() Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Directeur/Membre du Conseil | 21/08/2009 | - |
KIORA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | - | - |
Formation de Alain Maïore
Ecole Supérieure de Commerce de Toulouse | Graduate Degree |
Ecole Supérieure d'Agriculture d'Angers | Undergraduate Degree |
Statistiques
Internationale
France | 6 |
Etats-Unis | 2 |
Belgique | 2 |
Opérationnelle
Director/Board Member | 4 |
Founder | 2 |
Private Equity Investor | 1 |
Sectorielle
Finance | 3 |
Health Technology | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
KIORA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Ventech SA
![]() Ventech SA Investment ManagersFinance Ventech SA is part of the venture capital arm and a wholly-owned subsidiary of Natixis Private Equity (NPE), which in turn is a subsidiary of Paris-based Natixis SA (XP: KN). Ventech was established in 1998 and is located in Paris. The firm specializes in technology venture capital investing. Ventech manages venture capital funds for a clientele of European institutional investors, with NPE as their sponsor. The firm relies on international strategic alliances with seeding funds and venture capital firms in Germany, Switzerland, Israel, Japan and the US. | Finance |
Intrexon ActoBiotics NV
![]() Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Health Technology |
Kurma Partners SA
![]() Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Finance |
Mnemo Therapeutics SAS
![]() Mnemo Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Mnemo Therapeutics SAS is a French biotechnology company that develops cell therapies to create accessible cures for cancer patients. The company is based in Paris, FR, and has subsidiaries in the United States. The company applies a novel approach to cell therapy using its enfinit platform, a groundbreaking drug discovery engine. Mnemo is committed to addressing the challenges in the field of immuno-oncology, such as a lack of cancer-specific targets, long-term persistence, and sensitivity. The company aims to engineer the future of immunotherapies to transform the lives of people with cancer by discovering novel cancer-specific targets and boosting immune activity to treat solid tumors. The company was founded in 2019 by Alain Maïore and Michel Sadelain. Robert LaCaze has been the CEO of the company since 2022. | Commercial Services |
- Bourse
- Insiders
- Alain Maïore
- Expérience